-
2
-
-
30144443269
-
Paradoxical roles of the immune system during cancer development
-
DOI 10.1038/nrc1782
-
de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006;6: 24-37. (Pubitemid 43053650)
-
(2006)
Nature Reviews Cancer
, vol.6
, Issue.1
, pp. 24-37
-
-
De Visser, K.E.1
Eichten, A.2
Coussens, L.M.3
-
3
-
-
63049104211
-
Microenvironmental regulation of metastasis
-
Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009;9:239-252.
-
(2009)
Nat Rev Cancer
, vol.9
, pp. 239-252
-
-
Joyce, J.A.1
Pollard, J.W.2
-
4
-
-
0035901090
-
Inflammation and cancer: Back to Virchow?
-
DOI 10.1016/S0140-6736(00)04046-0
-
Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-545. (Pubitemid 32173595)
-
(2001)
Lancet
, vol.357
, Issue.9255
, pp. 539-545
-
-
Balkwill, F.1
Mantovani, A.2
-
5
-
-
0014887939
-
The concept of immunological surveillance
-
Burnet FM. The concept of immunological surveillance. Prog Exp Tumor Res 1970;13:1-27.
-
(1970)
Prog Exp Tumor Res
, vol.13
, pp. 1-27
-
-
Burnet, F.M.1
-
6
-
-
17644394616
-
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
-
DOI 10.1016/j.ccr.2005.02.013
-
Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005;7:211-217. (Pubitemid 40568680)
-
(2005)
Cancer Cell
, vol.7
, Issue.3
, pp. 211-217
-
-
Balkwill, F.1
Charles, K.A.2
Mantovani, A.3
-
7
-
-
33646413672
-
The global health burden of infection-associated cancers in the year
-
Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118:3030-3044.
-
(2002)
Int J Cancer
, vol.118
, pp. 3030-3044
-
-
Parkin, D.M.1
-
8
-
-
47949096781
-
Cancer-related inflammation
-
Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature 2008;454:436-444.
-
(2008)
Nature
, vol.454
, pp. 436-444
-
-
Mantovani, A.1
Allavena, P.2
Sica, A.3
-
9
-
-
25844490025
-
The interplay between innate and adaptive immunity regulates cancer development
-
DOI 10.1007/s00262-005-0702-5
-
De Visser KE, Coussens LM. The interplay between innate and adap-tive immunity regulates cancer development. Cancer Immunol Immu-nother 2005;54:1143-1152. (Pubitemid 41396818)
-
(2005)
Cancer Immunology, Immunotherapy
, vol.54
, Issue.11
, pp. 1143-1152
-
-
De Visser, K.E.1
Coussens, L.M.2
-
10
-
-
40049088602
-
The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages
-
DOI 10.1016/j.critrevonc.2007.07.004, PII S104084280700162X
-
Allavena P, Sica A, Solinas G, et al. The inflammatory micro-environ-ment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 2008;66:1-9. (Pubitemid 351324128)
-
(2008)
Critical Reviews in Oncology/Hematology
, vol.66
, Issue.1
, pp. 1-9
-
-
Allavena, P.1
Sica, A.2
Solinas, G.3
Porta, C.4
Mantovani, A.5
-
11
-
-
26644452073
-
Macrophage polarization comes of age
-
DOI 10.1016/j.immuni.2005.10.001, PII S1074761305003134
-
Mantovani A, Sica A, Locati M. Macrophage polarization comes of age. Immunity 2005;23:344-346. (Pubitemid 41443435)
-
(2005)
Immunity
, vol.23
, Issue.4
, pp. 344-346
-
-
Mantovani, A.1
Sica, A.2
Locati, M.3
-
12
-
-
28544446111
-
Monocyte and macrophage heterogeneity
-
DOI 10.1038/nri1733
-
Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005;5:953-964. (Pubitemid 41746764)
-
(2005)
Nature Reviews Immunology
, vol.5
, Issue.12
, pp. 953-964
-
-
Gordon, S.1
Taylor, P.R.2
-
13
-
-
3142724031
-
Toll-like receptor signalling
-
Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004;4:499-511. (Pubitemid 38931765)
-
(2004)
Nature Reviews Immunology
, vol.4
, Issue.7
, pp. 499-511
-
-
Akira, S.1
Takeda, K.2
-
14
-
-
34247621734
-
+ to post-genomics meta-analyses
-
DOI 10.1016/j.coi.2007.04.004, PII S0952791507000568, Lymphocyte activation/Lymphocyte effector functions
-
Walzer T, Jaeger S, Chaix J, et al. Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses. Curr Opin Im-munol 2007;19:365-372. (Pubitemid 46687010)
-
(2007)
Current Opinion in Immunology
, vol.19
, Issue.3
, pp. 365-372
-
-
Walzer, T.1
Jaeger, S.2
Chaix, J.3
Vivier, E.4
-
15
-
-
1542615649
-
Inhibitory NK-cell receptors on T cells: Witness of the past, actors of the future
-
Vivier E, Anfossi N. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat Rev Immunol 2004;4:190-198. (Pubitemid 38339085)
-
(2004)
Nature Reviews Immunology
, vol.4
, Issue.3
, pp. 190-198
-
-
Vivier, E.1
Anfossi, N.2
-
16
-
-
51049104872
-
The plasticity of gamma delta T cells: Innate immunity, antigen presentation and new immunotherapy
-
Casetti R, Martino A. The plasticity of gamma delta T cells: innate immunity, antigen presentation and new immunotherapy. Cell Mol Immunol 2008;5:161-170.
-
(2008)
Cell Mol Immunol
, vol.5
, pp. 161-170
-
-
Casetti, R.1
Martino, A.2
-
17
-
-
22944486712
-
Dendritic cell maturation by innate lymphocytes: Coordinated stimulation of innate and adaptive immunity
-
DOI 10.1084/jem.20050810
-
Munz C, Steinman RM, Fujii S. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J Exp Med 2005;202:203-207. (Pubitemid 41043815)
-
(2005)
Journal of Experimental Medicine
, vol.202
, Issue.2
, pp. 203-207
-
-
Munz, C.1
Steinman, R.M.2
Fujii, S.-I.3
-
18
-
-
0033581935
-
Selecting and maintaining a diverse T-cell repertoire
-
Goldrath AW, Bevan MJ. Selecting and maintaining a diverse T-cell repertoire. Nature 1999;402:255-262. (Pubitemid 129516254)
-
(1999)
Nature
, vol.402
, Issue.6759
, pp. 255-262
-
-
Goldrath, A.W.1
Bevan, M.J.2
-
19
-
-
0020534965
-
Somatic generation of antibody diversity
-
Tonegawa S. Somatic generation of antibody diversity. Nature 1983; 302:575-581.
-
(1983)
Nature
, vol.302
, pp. 575-581
-
-
Tonegawa, S.1
-
22
-
-
13444311714
-
Close encounters of different kinds: Dendritic cells and NK cells take centre stage
-
DOI 10.1038/nri1549
-
Degli-Esposti MA, Smyth MJ. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol 2005;5:112-124. (Pubitemid 40208901)
-
(2005)
Nature Reviews Immunology
, vol.5
, Issue.2
, pp. 112-124
-
-
Degli-Esposti, M.A.1
Smyth, M.J.2
-
24
-
-
5444243220
-
Interplay of natural killer cells and their receptors with the adaptive immune response
-
DOI 10.1038/ni1114
-
Raulet DH. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 2004;5:996-1002. (Pubitemid 41057716)
-
(2004)
Nature Immunology
, vol.5
, Issue.10
, pp. 996-1002
-
-
Raulet, D.H.1
-
25
-
-
5444234216
-
The interface between innate and adaptive immunity
-
DOI 10.1038/ni1004-971
-
Hoebe K, Janssen E, Beutler B. The interface between innate and adaptive immunity. Nat Immunol 2004;5:971-974. (Pubitemid 41057712)
-
(2004)
Nature Immunology
, vol.5
, Issue.10
, pp. 971-974
-
-
Hoebe, K.1
Janssen, E.2
Beutler, B.3
-
26
-
-
0038011833
-
Evolving concepts of rheumatoid arthritis
-
DOI 10.1038/nature01661
-
Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003; 423:356-361. (Pubitemid 40852711)
-
(2003)
Nature
, vol.423
, Issue.6937
, pp. 356-361
-
-
Firestein, G.S.1
-
27
-
-
0035874990
-
Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients
-
Schmielau J, Finn OJ. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res 2001;61:4756-4760. (Pubitemid 32691887)
-
(2001)
Cancer Research
, vol.61
, Issue.12
, pp. 4756-4760
-
-
Schmielau, J.1
Finn, O.J.2
-
28
-
-
43749102276
-
Immune surveillance: A balance between protumor and antitumor immunity
-
DOI 10.1016/j.gde.2007.12.007, PII S0959437X08000026
-
Ostrand-Rosenberg S. Immune surveillance: a balance between protu-mor and antitumor immunity. Curr Opin Genet Dev 2008;18:11-18. (Pubitemid 351694442)
-
(2008)
Current Opinion in Genetics and Development
, vol.18
, Issue.1
, pp. 11-18
-
-
Ostrand-Rosenberg, S.1
-
29
-
-
36048995442
-
NKT cells in immunoregulation of tumor immunity: A new immunoregulatory axis
-
DOI 10.1016/j.it.2007.05.008, PII S1471490607002293
-
Terabe M, Berzofsky JA. NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis. Trends Immunol 2007;28: 491-496. (Pubitemid 350087811)
-
(2007)
Trends in Immunology
, vol.28
, Issue.11
, pp. 491-496
-
-
Terabe, M.1
Berzofsky, J.A.2
-
30
-
-
46249124461
-
Immune escape as a fundamental trait of cancer: Focus on IDO
-
DOI 10.1038/onc.2008.35, PII ONC200835
-
Prendergast GC. Immune escape as a fundamental trait of cancer: focus on IDO. Oncogene 2008;27:3889-3900. (Pubitemid 351913639)
-
(2008)
Oncogene
, vol.27
, Issue.28
, pp. 3889-3900
-
-
Prendergast, G.C.1
-
31
-
-
0036852241
-
Cancer immunoediting: From immunosurveillance to tumor escape
-
DOI 10.1038/ni1102-991
-
Dunn GP, Bruce AT, Ikeda H, et al. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002;3:991-998. (Pubitemid 35363648)
-
(2002)
Nature Immunology
, vol.3
, Issue.11
, pp. 991-998
-
-
Dunn, G.P.1
Bruce, A.T.2
Ikeda, H.3
Old, L.J.4
Schreiber, R.D.5
-
32
-
-
46749123555
-
Beyond the increasing complexity of the immunomodulatory HLA-G molecule
-
Carosella ED, Favier B, Rouas-Freiss N, et al. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008; 111:4862-4870.
-
(2008)
Blood
, vol.111
, pp. 4862-4870
-
-
Carosella, E.D.1
Favier, B.2
Rouas-Freiss, N.3
-
33
-
-
34948818207
-
Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer
-
DOI 10.1016/j.lungcan.2007.06.011, PII S0169500207003418
-
Yie SM, Yang H, Ye SR, et al. Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer. Lung Cancer 2007;58:267-274. (Pubitemid 47516690)
-
(2007)
Lung Cancer
, vol.58
, Issue.2
, pp. 267-274
-
-
Yie, S.-m.1
Yang, H.2
Ye, S.-r.3
Li, K.4
Dong, D.-d.5
Lin, X.-m.6
-
34
-
-
0037180757
-
Inflammation and cancer
-
DOI 10.1038/nature01322
-
Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420: 860-867. (Pubitemid 36019639)
-
(2002)
Nature
, vol.420
, Issue.6917
, pp. 860-867
-
-
Coussens, L.M.1
Werb, Z.2
-
35
-
-
0034614637
-
The hallmarks of cancer
-
Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100: 57-70. (Pubitemid 30046295)
-
(2000)
Cell
, vol.100
, Issue.1
, pp. 57-70
-
-
Hanahan, D.1
Weinberg, R.A.2
-
36
-
-
33748987908
-
Cancer despite immunosurveillance: Immunoselection and immunosubversion
-
DOI 10.1038/nri1936, PII NRI1936
-
Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveil-lance: immunoselection and immunosubversion. Nat Rev Immunol 2006;6:715-727. (Pubitemid 44453458)
-
(2006)
Nature Reviews Immunology
, vol.6
, Issue.10
, pp. 715-727
-
-
Zitvogel, L.1
Tesniere, A.2
Kroemer, G.3
-
37
-
-
58149231380
-
Cancer: Inflaming metastasis
-
Mantovani A. Cancer: inflaming metastasis. Nature 2009;457:36-37.
-
(2009)
Nature
, vol.457
, pp. 36-37
-
-
Mantovani, A.1
-
38
-
-
77649193013
-
Immune infiltration in human tumors: A prognostic factor that should not be ignored
-
Pages F, Galon J, eu-Nosjean MC, et al. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 2010;29:1093-1102.
-
(2010)
Oncogene
, vol.29
, pp. 1093-1102
-
-
Pages, F.1
Galon, J.2
Eu-Nosjean, M.C.3
-
39
-
-
52449102477
-
Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures
-
Dieu-Nosjean MC, Antoine M, Danel C, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008;26:4410-4417.
-
(2008)
J Clin Oncol
, vol.26
, pp. 4410-4417
-
-
Dieu-Nosjean, M.C.1
Antoine, M.2
Danel, C.3
-
40
-
-
0027530535
-
Bronchus-associated lymphoid tissue (BALT) in human fetal and infant lung
-
Gould SJ, Isaacson PG. Bronchus-associated lymphoid tissue (BALT) in human fetal and infant lung. J Pathol 1993;169:229-234. (Pubitemid 23063461)
-
(1993)
Journal of Pathology
, vol.169
, Issue.2
, pp. 229-234
-
-
Gould, S.J.1
Isaacson, P.G.2
-
41
-
-
0033935484
-
Bronchus-associated lymphoid tissue (BALT) is not present in the normal adult lung but in different diseases
-
Tschernig T, Pabst R. Bronchus-associated lymphoid tissue (BALT) is not present in the normal adult lung but in different diseases. Patho-biology 2000;68:1-8. (Pubitemid 30434161)
-
(2000)
Pathobiology
, vol.68
, Issue.1
, pp. 1-8
-
-
Tschernig, T.1
Pabst, R.2
-
42
-
-
2642547301
-
Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma
-
DOI 10.1136/jcp.2003.014498
-
Esposito I, Menicagli M, Funel N, et al. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol 2004;57:630-636. (Pubitemid 38725766)
-
(2004)
Journal of Clinical Pathology
, vol.57
, Issue.6
, pp. 630-636
-
-
Esposito, I.1
Menicagli, M.2
Funel, N.3
Bergmann, F.4
Boggi, U.5
Mosca, F.6
Bevilacqua, G.7
Campani, D.8
-
43
-
-
0002598345
-
Mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis
-
Yano H, Kinuta M, Tateishi H, et al. Mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis. Gastric Cancer 1999;2:26-32.
-
(1999)
Gastric Cancer
, vol.2
, pp. 26-32
-
-
Yano, H.1
Kinuta, M.2
Tateishi, H.3
-
44
-
-
19344365408
-
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
-
DOI 10.1016/j.ccr.2005.04.014, PII S153561080500125X
-
de Visser KE, Korets LV, Coussens LM. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 2005;7:411-423. (Pubitemid 40719125)
-
(2005)
Cancer Cell
, vol.7
, Issue.5
, pp. 411-423
-
-
De Visser, K.E.1
Korets, L.V.2
Coussens, L.M.3
-
45
-
-
0033151608
-
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
-
Coussens LM, Raymond WW, Bergers G, et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogen-esis. Genes Dev 1999;13:1382-1397. (Pubitemid 29270244)
-
(1999)
Genes and Development
, vol.13
, Issue.11
, pp. 1382-1397
-
-
Coussens, L.M.1
Raymond, W.W.2
Bergers, G.3
Laig-Webster, M.4
Behrendtsen, O.5
Werb, Z.6
Caughey, G.H.7
Hanahan, D.8
-
46
-
-
7944223098
-
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
-
DOI 10.1016/j.ccr.2004.09.028, PII S1535610804003009
-
Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 2004;6: 447-458. (Pubitemid 39469981)
-
(2004)
Cancer Cell
, vol.6
, Issue.5
, pp. 447-458
-
-
Sparmann, A.1
Bar-Sagi, D.2
-
47
-
-
34248172324
-
Altered macrophage differentiation and immune dysfunction in tumor development
-
DOI 10.1172/JCI31422
-
Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. JClin Invest 2007;117:1155-1166. (Pubitemid 46718400)
-
(2007)
Journal of Clinical Investigation
, vol.117
, Issue.5
, pp. 1155-1166
-
-
Sica, A.1
Bronte, V.2
-
48
-
-
35548982639
-
Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels
-
DOI 10.1016/j.cell.2007.08.038, PII S0092867407011014
-
Fischer C, Jonckx B, Mazzone M, et al. Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 2007;131:463-475. (Pubitemid 350007692)
-
(2007)
Cell
, vol.131
, Issue.3
, pp. 463-475
-
-
Fischer, C.1
Jonckx, B.2
Mazzone, M.3
Zacchigna, S.4
Loges, S.5
Pattarini, L.6
Chorianopoulos, E.7
Liesenborghs, L.8
Koch, M.9
De Mol, M.10
Autiero, M.11
Wyns, S.12
Plaisance, S.13
Moons, L.14
Van Rooijen, N.15
Giacca, M.16
Stassen, J.-M.17
Dewerchin, M.18
Collen, D.19
Carmeliet, P.20
more..
-
49
-
-
28644432204
-
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
-
DOI 10.1038/nature04186
-
Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haema-topoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005;438:820-827. (Pubitemid 41753060)
-
(2005)
Nature
, vol.438
, Issue.7069
, pp. 820-827
-
-
Kaplan, R.N.1
Riba, R.D.2
Zacharoulis, S.3
Bramley, A.H.4
Vincent, L.5
Costa, C.6
MacDonald, D.D.7
Jin, D.K.8
Shido, K.9
Kerns, S.A.10
Zhu, Z.11
Hicklin, D.12
Wu, Y.13
Port, J.L.14
Altorki, N.15
Port, E.R.16
Ruggero, D.17
Shmelkov, S.V.18
Jensen, K.K.19
Rafii, S.20
Lyden, D.21
more..
-
50
-
-
36849013036
-
Bv8 regulates myeloid-cell-dependent tumour angiogenesis
-
DOI 10.1038/nature06348, PII NATURE06348
-
Shojaei F, Wu X, Zhong C, et al. Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 2007;450:825-831. (Pubitemid 350231321)
-
(2007)
Nature
, vol.450
, Issue.7171
, pp. 825-831
-
-
Shojaei, F.1
Wu, X.2
Zhong, C.3
Yu, L.4
Liang, X.-H.5
Yao, J.6
Blanchard, D.7
Bais, C.8
Peale, F.V.9
Van Bruggen, N.10
Ho, C.11
Ross, J.12
Tan, M.13
Carano, R.A.D.14
Meng, Y.G.15
Ferrara, N.16
-
51
-
-
35448954376
-
Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression
-
DOI 10.1158/0008-5472.CAN-07-2354
-
Bunt SK, Yang L, Sinha P, et al. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived sup-pressor cells and limits tumor progression. Cancer Res 2007;67: 10019-10026. (Pubitemid 47621253)
-
(2007)
Cancer Research
, vol.67
, Issue.20
, pp. 10019-10026
-
-
Bunt, S.K.1
Yang, L.2
Sinha, P.3
Clements, V.K.4
Leips, J.5
Ostrand-Rosenberg, S.6
-
52
-
-
0034721666
-
MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis
-
Coussens LM, Tinkle CL, Hanahan D, et al. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000; 103:481-490.
-
(2000)
Cell
, vol.103
, pp. 481-490
-
-
Coussens, L.M.1
Tinkle, C.L.2
Hanahan, D.3
-
53
-
-
0035911221
-
Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy
-
Lin EY, Nguyen AV, Russell RG, et al. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001;193:727-740.
-
(2001)
J Exp Med
, vol.193
, pp. 727-740
-
-
Lin, E.Y.1
Nguyen, A.V.2
Russell, R.G.3
-
54
-
-
0026689558
-
The origin and function of tumor-associated macrophages
-
Mantovani A, Bottazzi B, Colotta F, et al. The origin and function of tumor-associated macrophages. Immunol Today 1992;13:265-270.
-
(1992)
Immunol Today
, vol.13
, pp. 265-270
-
-
Mantovani, A.1
Bottazzi, B.2
Colotta, F.3
-
55
-
-
36148960830
-
Inflammatory cell infiltration of tumors: Jekyll or Hyde
-
DOI 10.1007/s10555-007-9072-0, Forty Years of Metastasis Research: A Tribute to Dr. Isaiah J. Fidler
-
Talmadge JE, Donkor M, Scholar E. Inflammatory cell infiltration of tumors: Jekyll or Hyde. Cancer Metastasis Rev 2007;26:373-400. (Pubitemid 350115102)
-
(2007)
Cancer and Metastasis Reviews
, vol.26
, Issue.3-4
, pp. 373-400
-
-
Talmadge, J.E.1
Donkor, M.2
Scholar, E.3
-
56
-
-
0036187615
-
The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies
-
DOI 10.1002/path.1027
-
Bingle L, Brown NJ, Lewis CE. The role of tumour-associated mac-rophages in tumour progression: implications for new anticancer ther-apies. JPathol 2002;196:254-265. (Pubitemid 34189413)
-
(2002)
Journal of Pathology
, vol.196
, Issue.3
, pp. 254-265
-
-
Bingle, L.1
Brown, N.J.2
Lewis, C.E.3
-
57
-
-
47949090079
-
The role of myeloid cells in the promotion of tumour angiogenesis
-
Murdoch C, Muthana M, Coffelt SB, et al. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 2008;8:618-631.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 618-631
-
-
Murdoch, C.1
Muthana, M.2
Coffelt, S.B.3
-
58
-
-
54049134747
-
Subsets of myeloid-derived suppressor cells in tumor-bearing mice
-
Youn JI, Nagaraj S, Collazo M, et al. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008;181:5791-5802.
-
(2008)
J Immunol
, vol.181
, pp. 5791-5802
-
-
Youn, J.I.1
Nagaraj, S.2
Collazo, M.3
-
59
-
-
34948852371
-
Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors
-
DOI 10.1038/nm1649, PII NM1649
-
Soucek L, Lawlor ER, Soto D, et al. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med 2007;13:1211-1218. (Pubitemid 47530639)
-
(2007)
Nature Medicine
, vol.13
, Issue.10
, pp. 1211-1218
-
-
Soucek, L.1
Lawlor, E.R.2
Soto, D.3
Shchors, K.4
Swigart, L.B.5
Evan, G.I.6
-
60
-
-
9244230028
-
Mast cell contribution to angiogenesis related to tumour progression
-
DOI 10.1111/j.1365-2222.2004.02104.x
-
Ribatti D, Crivellato E, Roccaro AM, et al. Mast cell contribution to angiogenesis related to tumour progression. Clin Exp Allergy 2004;34: 1660-1664. (Pubitemid 39551516)
-
(2004)
Clinical and Experimental Allergy
, vol.34
, Issue.11
, pp. 1660-1664
-
-
Ribatti, D.1
Crivellato, E.2
Roccaro, A.M.3
Ria, R.4
Vacca, A.5
-
61
-
-
24944587964
-
Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors
-
DOI 10.1016/j.ccr.2005.08.002, PII S1535610805002606
-
De Palma M, Venneri MA, Galli R, et al. Tie2 identifies a hematopoi-etic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005;8:211-226. (Pubitemid 41317592)
-
(2005)
Cancer Cell
, vol.8
, Issue.3
, pp. 211-226
-
-
De Palma, M.1
Venneri, M.A.2
Galli, R.3
Sergi, L.S.4
Politi, L.S.5
Sampaolesi, M.6
Naldini, L.7
-
62
-
-
34249979533
-
Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer
-
DOI 10.1182/blood-2006-10-053504
-
Venneri MA, De PM, Ponzoni M, et al. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood 2007;109:5276-5285. (Pubitemid 46890548)
-
(2007)
Blood
, vol.109
, Issue.12
, pp. 5276-5285
-
-
Venneri, M.A.1
De Palma, M.2
Ponzoni, M.3
Pucci, F.4
Scielzo, C.5
Zonari, E.6
Mazzieri, R.7
Doglioni, C.8
Naldini, L.9
-
63
-
-
0036839143
-
Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
-
DOI 10.1016/S1471-4906(02)02302-5, PII S1471490602023025
-
Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mono-nuclear phagocytes. Trends Immunol 2002;23:549-555. (Pubitemid 35223554)
-
(2002)
Trends in Immunology
, vol.23
, Issue.11
, pp. 549-555
-
-
Mantovani, A.1
Sozzani, S.2
Locati, M.3
Allavena, P.4
Sica, A.5
-
64
-
-
0037265240
-
Alternative activation of macrophages
-
DOI 10.1038/nri978
-
Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35. (Pubitemid 37328697)
-
(2003)
Nature Reviews Immunology
, vol.3
, Issue.1
, pp. 23-35
-
-
Gordon, S.1
-
65
-
-
7644231561
-
The chemokine system in diverse forms of macrophage activation and polarization
-
DOI 10.1016/j.it.2004.09.015, PII S1471490604002959
-
Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Im-munol 2004;25:677-686. (Pubitemid 39457982)
-
(2004)
Trends in Immunology
, vol.25
, Issue.12
, pp. 677-686
-
-
Mantovani, A.1
Sica, A.2
Sozzani, S.3
Allavena, P.4
Vecchi, A.5
Locati, M.6
-
66
-
-
56749174940
-
Exploring the full spectrum of macrophage activation
-
Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008;8:958-969.
-
(2008)
Nat Rev Immunol
, vol.8
, pp. 958-969
-
-
Mosser, D.M.1
Edwards, J.P.2
-
67
-
-
0347123433
-
Tumour-educated macrophages promote tumour progression and metastasis
-
Pollard JW. Tumour-educated macrophages promote tumour progres-sion and metastasis. Nat Rev Cancer 2004;4:71-78. (Pubitemid 38082155)
-
(2004)
Nature Reviews Cancer
, vol.4
, Issue.1
, pp. 71-78
-
-
Pollard, J.W.1
-
68
-
-
31044433663
-
Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis
-
DOI 10.1016/j.cell.2006.01.007, PII S0092867406000559
-
Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006;124:263-266. (Pubitemid 43121975)
-
(2006)
Cell
, vol.124
, Issue.2
, pp. 263-266
-
-
Condeelis, J.1
Pollard, J.W.2
-
69
-
-
0742286811
-
Derangement of immune responses by myeloid suppressor cells
-
DOI 10.1007/s00262-003-0443-2
-
Serafini P, De SC, Marigo I, et al. Derangement of immune responses by myeloid suppressor cells. Cancer Immunol Immunother 2004;53: 64-72. (Pubitemid 38161211)
-
(2004)
Cancer Immunology, Immunotherapy
, vol.53
, Issue.2
, pp. 64-72
-
-
Serafini, P.1
De Santo, C.2
Marigo, I.3
Cingarlini, S.4
Dolcetti, L.5
Gallina, G.6
Zanovello, P.7
Bronte, V.8
-
70
-
-
0035339932
-
+ myeloid cells
-
Gabrilovich DI, Velders MP, Sotomayor EM, et al. Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J Immunol 2001;166:5398-5406. (Pubitemid 32374159)
-
(2001)
Journal of Immunology
, vol.166
, Issue.9
, pp. 5398-5406
-
-
Gabrilovich, D.I.1
Velders, M.P.2
Sotomayor, E.M.3
Kast, W.M.4
-
72
-
-
43049139914
-
Inflammation and tumor microenvironments: Defining the migratory itinerary of mesenchymal stem cells
-
DOI 10.1038/gt.2008.39, PII GT200839
-
Spaeth E, Klopp A, Dembinski J, et al. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther 2008;15:730-738. (Pubitemid 351627356)
-
(2008)
Gene Therapy
, vol.15
, Issue.10
, pp. 730-738
-
-
Spaeth, E.1
Klopp, A.2
Dembinski, J.3
Andreeff, M.4
Marini, F.5
-
73
-
-
34948896045
-
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
-
DOI 10.1038/nature06188, PII NATURE06188
-
Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007;449: 557-563. (Pubitemid 47525152)
-
(2007)
Nature
, vol.449
, Issue.7162
, pp. 557-563
-
-
Karnoub, A.E.1
Dash, A.B.2
Vo, A.P.3
Sullivan, A.4
Brooks, M.W.5
Bell, G.W.6
Richardson, A.L.7
Polyak, K.8
Tubo, R.9
Weinberg, R.A.10
-
74
-
-
0036772338
-
Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem cells reveals a lack of distinction
-
DOI 10.1089/10763270260424105
-
Lodie TA, Blickarz CE, Devarakonda TJ, et al. Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem cells reveals a lack of distinction. Tissue Eng 2002;8:739-751. (Pubitemid 35239752)
-
(2002)
Tissue Engineering
, vol.8
, Issue.5
, pp. 739-751
-
-
Lodie, T.A.1
Blickarz, C.E.2
Devarakonda, T.J.3
Chufa, H.E.4
Dash, A.B.5
Clarke, J.6
Gleneck, K.7
Shihabuddin, L.8
Tubo, R.9
-
75
-
-
69549112977
-
The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma
-
Al-Shibli K, Al-Saad S, Donnem T, et al. The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma. Histopathology 2009;55:301-312.
-
(2009)
Histopathology
, vol.55
, pp. 301-312
-
-
Al-Shibli, K.1
Al-Saad, S.2
Donnem, T.3
-
76
-
-
53149083361
-
Predominant infiltration of macro-phages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer
-
Kawai O, Ishii G, Kubota K, et al. Predominant infiltration of macro-phages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Cancer 2008;113:1387-1395.
-
(2008)
Cancer
, vol.113
, pp. 1387-1395
-
-
Kawai, O.1
Ishii, G.2
Kubota, K.3
-
77
-
-
32644466544
-
Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer
-
DOI 10.1200/JCO.2005.01.4910
-
Welsh TJ, Green RH, Richardson D, et al. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol 2005;23:8959-8967. (Pubitemid 46211481)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.35
, pp. 8959-8967
-
-
Welsh, T.J.1
Green, R.H.2
Richardson, D.3
Waller, D.A.4
O'Byrne, K.J.5
Bradding, P.6
-
78
-
-
77952937103
-
The M1 form of tumor-associated macro-phages in non-small cell lung cancer is positively associated with survival time
-
Ma J, Liu L, Che G, et al. The M1 form of tumor-associated macro-phages in non-small cell lung cancer is positively associated with survival time. BMC Cancer 2010;10:112.
-
(2010)
BMC Cancer
, vol.10
, pp. 112
-
-
Ma, J.1
Liu, L.2
Che, G.3
-
79
-
-
58849166142
-
Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associ-ated with extended survival
-
Ohri CM, Shikotra A, Green RH, et al. Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associ-ated with extended survival. Eur Respir J2009;33:118-126.
-
(2009)
Eur Respir J
, vol.33
, pp. 118-126
-
-
Ohri, C.M.1
Shikotra, A.2
Green, R.H.3
-
80
-
-
53549114206
-
NK cells and cancer immunosurveillance
-
Waldhauer I, Steinle A. NK cells and cancer immunosurveillance. Oncogene 2008;27:5932-5943.
-
(2008)
Oncogene
, vol.27
, pp. 5932-5943
-
-
Waldhauer, I.1
Steinle, A.2
-
81
-
-
42449151214
-
Functions of natural killer cells
-
DOI 10.1038/ni1582, PII NI1582
-
Vivier E, Tomasello E, Baratin M, et al. Functions of natural killer cells. Nat Immunol 2008;9:503-510. (Pubitemid 351560519)
-
(2008)
Nature Immunology
, vol.9
, Issue.5
, pp. 503-510
-
-
Vivier, E.1
Tomasello, E.2
Baratin, M.3
Walzer, T.4
Ugolini, S.5
-
82
-
-
0034572835
-
NKT cells and tumor immunity\a double-edged sword
-
Smyth MJ, Godfrey DI. NKT cells and tumor immunity\a double-edged sword. Nat Immunol 2000;1:459-460.
-
(2000)
Nat Immunol
, vol.1
, pp. 459-460
-
-
Smyth, M.J.1
Godfrey, D.I.2
-
83
-
-
1542357608
-
Natural killer lymphocytes: Biology, development, and function
-
DOI 10.1007/s00262-003-0478-4
-
Papamichail M, Perez SA, Gritzapis AD, et al. Natural killer lympho-cytes: biology, development, and function. Cancer Immunol Immu-nother 2004;53:176-186. (Pubitemid 38328040)
-
(2004)
Cancer Immunology, Immunotherapy
, vol.53
, Issue.3
, pp. 176-186
-
-
Papamichail, M.1
Perez, S.A.2
Gritzapis, A.D.3
Baxevanis, C.N.4
-
84
-
-
0034569025
-
NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway
-
Terabe M, Matsui S, Noben-Trauth N, et al. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 2000;1:515-520.
-
(2000)
Nat Immunol
, vol.1
, pp. 515-520
-
-
Terabe, M.1
Matsui, S.2
Noben-Trauth, N.3
-
85
-
-
0034569294
-
Immune suppression and skin cancer development: Regulation by NKT cells
-
Moodycliffe AM, Nghiem D, Clydesdale G, et al. Immune suppression and skin cancer development: regulation by NKT cells. Nat Immunol 2000;1:521-525.
-
(2000)
Nat Immunol
, vol.1
, pp. 521-525
-
-
Moodycliffe, A.M.1
Nghiem, D.2
Clydesdale, G.3
-
86
-
-
57649101649
-
CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer
-
Wang RF. CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer. Hum Immunol 2008;69:811-814.
-
(2008)
Hum Immunol
, vol.69
, pp. 811-814
-
-
Wang, R.F.1
-
88
-
-
33745820353
-
+ regulatory T cells
-
Jarnicki AG, Lysaght J, Todryk S, et al. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells. J Immunol 2006;177:896-904. (Pubitemid 44036590)
-
(2006)
Journal of Immunology
, vol.177
, Issue.2
, pp. 896-904
-
-
Jarnicki, A.G.1
Lysaght, J.2
Todryk, S.3
Mills, K.H.G.4
-
89
-
-
16844379997
-
Immunosuppressive networks in the tumour environment and their therapeutic relevance
-
DOI 10.1038/nrc1586
-
Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 2005;5:263-274. (Pubitemid 40488632)
-
(2005)
Nature Reviews Cancer
, vol.5
, Issue.4
, pp. 263-274
-
-
Zou, W.1
-
90
-
-
37249067503
-
+ regulatory T cells mediate immunosuppression in prostate cancer
-
DOI 10.1158/1078-0432.CCR-07-0842
-
Kiniwa Y, Miyahara Y, Wang HY, et al. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Clin Cancer Res 2007;13:6947-6958. (Pubitemid 350276874)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.23
, pp. 6947-6958
-
-
Kiniwa, Y.1
Miyahara, Y.2
Wang, H.Y.3
Peng, W.4
Peng, G.5
Wheeler, T.M.6
Thompson, T.C.7
Old, L.J.8
Wang, R.-F.9
-
91
-
-
0037128654
-
Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells
-
DOI 10.1084/jem.20011603
-
Gilliet M, Liu YJ. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 2002; 195:695-704. (Pubitemid 34259715)
-
(2002)
Journal of Experimental Medicine
, vol.195
, Issue.6
, pp. 695-704
-
-
Gilliet, M.1
Liu, Y.-J.2
-
92
-
-
4644237613
-
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
-
DOI 10.1038/nm1093
-
Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004;10:942-949. (Pubitemid 39273735)
-
(2004)
Nature Medicine
, vol.10
, Issue.9
, pp. 942-949
-
-
Curiel, T.J.1
Coukos, G.2
Zou, L.3
Alvarez, X.4
Cheng, P.5
Mottram, P.6
Evdemon-Hogan, M.7
Conejo-Garcia, J.R.8
Zhang, L.9
Burow, M.10
Zhu, Y.11
Wei, S.12
Kryczek, I.13
Daniel, B.14
Gordon, A.15
Myers, L.16
Lackner, A.17
Disis, M.L.18
Knutson, K.L.19
Chen, L.20
Zou, W.21
more..
-
93
-
-
0036569127
-
Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation
-
Woo EY, Yeh H, Chu CS, et al. Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol 2002;168:4272-4276. (Pubitemid 34441324)
-
(2002)
Journal of Immunology
, vol.168
, Issue.9
, pp. 4272-4276
-
-
Woo, E.Y.1
Yeh, H.2
Chu, C.S.3
Schlienger, K.4
Carroll, R.G.5
Riley, J.L.6
Kaiser, L.R.7
June, C.H.8
-
94
-
-
34247261531
-
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
-
DOI 10.1200/JCO.2006.05.9584
-
Bates GJ, Fox SB, Han C, et al. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 2006;24:5373-5380. (Pubitemid 46623168)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.34
, pp. 5373-5380
-
-
Bates, G.J.1
Fox, S.B.2
Han, C.3
Leek, R.D.4
Garcia, J.F.5
Harris, A.L.6
Banham, A.H.7
-
95
-
-
34447277894
-
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
-
DOI 10.1200/JCO.2006.09.4565
-
Gao Q, Qiu SJ, Fan J, et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carci-noma after resection. J Clin Oncol 2007;25:2586-2593. (Pubitemid 47041232)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.18
, pp. 2586-2593
-
-
Gao, Q.1
Qiu, S.-J.2
Fan, J.3
Zhou, J.4
Wang, X.-Y.5
Xiao, Y.-S.6
Xu, Y.7
Li, Y.-W.8
Tang, Z.-Y.9
-
96
-
-
0033571105
-
Induction of tumor immunity by removing CD25+CD4+ T cells: A common basis between tumor immunity and autoimmunity
-
Shimizu J, Yamazaki S, Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999;163:5211-5218.
-
(1999)
J Immunol
, vol.163
, pp. 5211-5218
-
-
Shimizu, J.1
Yamazaki, S.2
Sakaguchi, S.3
-
97
-
-
0033168037
-
Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody
-
Onizuka S, Tawara I, Shimizu J, et al. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 1999;59:3128-3133. (Pubitemid 29316012)
-
(1999)
Cancer Research
, vol.59
, Issue.13
, pp. 3128-3133
-
-
Onizuka, S.1
Tawara, I.2
Shimizu, J.3
Sakaguchi, S.4
Fujita, T.5
Nakayama, E.6
-
98
-
-
0036240261
-
The development of immunotherapies for non-small cell lung cancer
-
DOI 10.1517/14712598.2.3.265
-
Salgaller ML. The development of immunotherapies for non-small cell lung cancer. Expert Opin Biol Ther 2002;2:265-278. (Pubitemid 34464808)
-
(2002)
Expert Opinion on Biological Therapy
, vol.2
, Issue.3
, pp. 265-278
-
-
Salgaller, M.L.1
-
99
-
-
0036846118
-
Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression
-
DOI 10.1067/mlc.2002.128317
-
Kataki A, Scheid P, Piet M, et al. Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression. J Lab Clin Med 2002;140: 320-328. (Pubitemid 35302024)
-
(2002)
Journal of Laboratory and Clinical Medicine
, vol.140
, Issue.5
, pp. 320-328
-
-
Kataki, A.1
Scheid, P.2
Piet, M.3
Marie, B.4
Martinet, N.5
Martinet, Y.6
Vignaud, J.-M.7
-
100
-
-
33744990848
-
Expression of Foxp3 in non-small cell lung cancer patients is significantly higher in tumor tissues than in normal tissues, especially in tumors smaller than 30 mm
-
Ishibashi Y, Tanaka S, Tajima K, et al. Expression of Foxp3 in non-small cell lung cancer patients is significantly higher in tumor tissues than in normal tissues, especially in tumors smaller than 30 mm. Oncol Rep 2006;15:1315-1319.
-
(2006)
Oncol Rep
, vol.15
, pp. 1315-1319
-
-
Ishibashi, Y.1
Tanaka, S.2
Tajima, K.3
-
101
-
-
0031865403
-
Tumour-infiltrating lymphocytes in non-small cell lung cancer are activated T lymphocytes
-
Kuo SH, Chang DB, Lee YC, et al. Tumour-infiltrating lymphocytes in non-small cell lung cancer are activated T lymphocytes. Respirology 1998;3:55-59.
-
(1998)
Respirology
, vol.3
, pp. 55-59
-
-
Kuo, S.H.1
Chang, D.B.2
Lee, Y.C.3
-
102
-
-
77951938715
-
Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class i molecules in lung cancer patients
-
Schutt P, Schutt B, Switala M, et al. Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients. Hum Immunol 2010;71:489-495.
-
(2010)
Hum Immunol
, vol.71
, pp. 489-495
-
-
Schutt, P.1
Schutt, B.2
Switala, M.3
-
103
-
-
78649416004
-
Clinical relevance and functional implications for human leukocyte antigen-G expression in non-small-cell lung cancer
-
Lin A, Zhu CC, Chen HX, et al. Clinical relevance and functional implications for human leukocyte antigen-G expression in non-small-cell lung cancer. J Cell Mol Med 2010;14:2318-2329.
-
(2010)
J Cell Mol Med
, vol.14
, pp. 2318-2329
-
-
Lin, A.1
Zhu, C.C.2
Chen, H.X.3
-
104
-
-
33645012941
-
Non-classical HLA-G antigen and its role in the cancer progression
-
Tripathi P, Agrawal S. Non-classical HLA-G antigen and its role in the cancer progression. Cancer Invest 2006;24:178-186.
-
(2006)
Cancer Invest
, vol.24
, pp. 178-186
-
-
Tripathi, P.1
Agrawal, S.2
-
105
-
-
1842843545
-
Antitumor cytotoxic t-lymphocyte response in human lung carcinoma: Identification of a tumor-associated antigen
-
DOI 10.1034/j.1600-065X.2002.18810.x
-
Mami-Chouaib F, Echchakir H, Dorothee G, et al. Antitumor cytotoxic T-lymphocyte response in human lung carcinoma: identification of a tumor-associated antigen. Immunol Rev 2002;188:114-121. (Pubitemid 35398869)
-
(2002)
Immunological Reviews
, vol.188
, pp. 114-121
-
-
Mami-Chouaib, F.1
Echchakir, H.2
Dorothee, G.3
Vergnon, I.4
Chouaib, S.5
-
106
-
-
62449250053
-
Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome
-
Gobert M, Treilleux I, driss-Vermare N, et al. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res 2009;69:2000-2009.
-
(2009)
Cancer Res
, vol.69
, pp. 2000-2009
-
-
Gobert, M.1
Treilleux, I.2
Driss-Vermare, N.3
-
107
-
-
0025735629
-
The dendritic cell system and its role in immunogenic-ity
-
Steinman RM. The dendritic cell system and its role in immunogenic-ity. Annu Rev Immunol 1991;9:271-296.
-
(1991)
Annu Rev Immunol
, vol.9
, pp. 271-296
-
-
Steinman, R.M.1
-
108
-
-
0036849944
-
The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer
-
Inoshima N, Nakanishi Y, Minami T, et al. The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis ofnon-small cell lung cancer. Clin Cancer Res 2002;8: 3480-3486. (Pubitemid 35340725)
-
(2002)
Clinical Cancer Research
, vol.8
, Issue.11
, pp. 3480-3486
-
-
Inoshima, N.1
Nakanishi, Y.2
Minami, T.3
Izumi, M.4
Takayama, K.5
Yoshino, I.6
Hara, N.7
-
109
-
-
77952416002
-
The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer
-
Dai F, Liu L, Che G, et al. The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer. BMC Cancer 2010;10:220.
-
(2010)
BMC Cancer
, vol.10
, pp. 220
-
-
Dai, F.1
Liu, L.2
Che, G.3
-
110
-
-
49649083838
-
Dendritic cell infiltration pattern along the colorectal adenoma-carcinoma sequence
-
Yuan A, Steigen SE, Goll R, et al. Dendritic cell infiltration pattern along the colorectal adenoma-carcinoma sequence. APMIS 2008;116: 445-456.
-
(2008)
APMIS
, vol.116
, pp. 445-456
-
-
Yuan, A.1
Steigen, S.E.2
Goll, R.3
-
111
-
-
33644535813
-
Dendritic cell infiltration and prognosis of human hepatocellular carcinoma
-
Cai XY, Gao Q, Qiu SJ, et al. Dendritic cell infiltration and prognosis of human hepatocellular carcinoma. J Cancer Res Clin Oncol 2006; 132:293-301.
-
(2006)
J Cancer Res Clin Oncol
, vol.132
, pp. 293-301
-
-
Cai, X.Y.1
Gao, Q.2
Qiu, S.J.3
-
112
-
-
0041976915
-
CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer
-
DOI 10.1038/sj.bjc.6601114
-
Coventry BJ, Morton J. CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer. Br J Cancer 2003;89: 533-538. (Pubitemid 37026439)
-
(2003)
British Journal of Cancer
, vol.89
, Issue.3
, pp. 533-538
-
-
Coventry, B.J.1
Morton, J.2
-
113
-
-
64849114869
-
Human dendritic cells produce TGF-beta 1 under the influence of lung carcinoma cells and prime the differentiation of CD4+CD25+Foxp3+ regulatory T cells
-
Dumitriu IE, Dunbar DR, Howie SE, et al. Human dendritic cells produce TGF-beta 1 under the influence of lung carcinoma cells and prime the differentiation of CD4+CD25+Foxp3+ regulatory T cells. J Immunol 2009;182:2795-2807.
-
(2009)
J Immunol
, vol.182
, pp. 2795-2807
-
-
Dumitriu, I.E.1
Dunbar, D.R.2
Howie, S.E.3
-
114
-
-
58149252418
-
Pulmonary stromal cells induce the generation of regulatory DC attenuating T-cell-mediated lung inflam-mation
-
Li Q, Guo Z, Xu X, et al. Pulmonary stromal cells induce the generation of regulatory DC attenuating T-cell-mediated lung inflam-mation. Eur J Immunol 2008;38:2751-2761.
-
(2008)
Eur J Immunol
, vol.38
, pp. 2751-2761
-
-
Li, Q.1
Guo, Z.2
Xu, X.3
-
115
-
-
39049139508
-
- cells and display an impaired capability to kill tumor cells
-
DOI 10.1002/cncr.23239
-
Carrega P, Morandi B, Costa R, et al. Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells. Cancer 2008;112:863-875. (Pubitemid 351240580)
-
(2008)
Cancer
, vol.112
, Issue.4
, pp. 863-875
-
-
Carrega, P.1
Morandi, B.2
Costa, R.3
Frumento, G.4
Forte, G.5
Altavilla, G.6
Ratto, G.B.7
Mingari, M.C.8
Moretta, L.9
Ferlazzo, G.10
-
116
-
-
37549028767
-
Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer
-
Esendagli G, Bruderek K, Goldmann T, et al. Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer. Lung Cancer 2008;59:32-40.
-
(2008)
Lung Cancer
, vol.59
, pp. 32-40
-
-
Esendagli, G.1
Bruderek, K.2
Goldmann, T.3
-
117
-
-
0036136050
-
Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer
-
DOI 10.1016/S0169-5002(01)00292-6, PII S0169500201002926
-
Villegas FR, Coca S, Villarrubia VG, et al. Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. Lung Cancer 2002;35:23-28. (Pubitemid 34028087)
-
(2002)
Lung Cancer
, vol.35
, Issue.1
, pp. 23-28
-
-
Villegas, F.R.1
Coca, S.2
Villarrubia, V.G.3
Jimenez, R.4
Chillon, M.J.5
Jareno, J.6
Zuil, M.7
Callol, L.8
-
118
-
-
0035384386
-
The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma
-
Takanami I, Takeuchi K, Giga M. The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma. J Thorac Car-diovasc Surg 2001;121:1058-1063.
-
(2001)
J Thorac Car-diovasc Surg
, vol.121
, pp. 1058-1063
-
-
Takanami, I.1
Takeuchi, K.2
Giga, M.3
-
119
-
-
49749146393
-
Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages
-
Hiraoka K, Zenmyo M, Watari K, et al. Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages. Cancer Sci 2008;99:1595-1602.
-
(2008)
Cancer Sci
, vol.99
, pp. 1595-1602
-
-
Hiraoka, K.1
Zenmyo, M.2
Watari, K.3
-
120
-
-
39149102867
-
The significance and relationship between mast cells and tumour angiogenesis in non-small cell lung carcinoma
-
Dundar E, Oner U, Peker BC, et al. The significance and relationship between mast cells and tumour angiogenesis in non-small cell lung carcinoma. JInt Med Res 2008;36:88-95. (Pubitemid 351255974)
-
(2008)
Journal of International Medical Research
, vol.36
, Issue.1
, pp. 88-95
-
-
Dundar, E.1
Oner, U.2
Peker, B.C.3
Metintas, M.4
Isiksoy, S.5
Ak, G.6
-
121
-
-
77951095411
-
The prognostic value of intraepithelial and stromal CD3-CD117-and CD138-positive cells in non-small cell lung carcinoma
-
Al-Shibli K, Al-Saad S, Andersen S, et al. The prognostic value of intraepithelial and stromal CD3-, CD117-and CD138-positive cells in non-small cell lung carcinoma. APMIS 2010;118:371-382.
-
(2010)
APMIS
, vol.118
, pp. 371-382
-
-
Al-Shibli, K.1
Al-Saad, S.2
Andersen, S.3
-
122
-
-
0032693268
-
Correlation between mast cells and survival rates in patients with pulmonary adenocarcinoma
-
DOI 10.1016/S0169-5002(99)00076-8, PII S0169500299000768
-
Tomita M, Matsuzaki Y, Onitsuka T. Correlation between mast cells and survival rates in patients with pulmonary adenocarcinoma. Lung Cancer 1999;26:103-108. (Pubitemid 29492898)
-
(1999)
Lung Cancer
, vol.26
, Issue.2
, pp. 103-108
-
-
Tomita, M.1
Matsuzaki, Y.2
Onitsuka, T.3
-
123
-
-
0034659880
-
Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma
-
DOI 10.1002/1097-0142(20000615)88:12<2686::AID-CNCR6>3.0.CO;2-6
-
Takanami I, Takeuchi K, Naruke M. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer 2000;88:2686-2692. (Pubitemid 30417928)
-
(2000)
Cancer
, vol.88
, Issue.12
, pp. 2686-2692
-
-
Takanami, I.1
Takeuchi, K.2
Naruke, M.3
-
124
-
-
0024530868
-
Morphometric and morphologic evaluations in stage III non-small cell lung cancers. Prognostic significance of quantitative assessment of infiltrating lymphoid cells
-
DOI 10.1002/1097-0142(19890115)63:2<309::AID-CNCR2820630218>3.0. CO;2-N
-
Lee TK, Horner RD, Silverman JF, et al. Morphometric and morpho-logic evaluations in stage III non-small cell lung cancers. Prognostic significance of quantitative assessment of infiltrating lymphoid cells. Cancer 1989;63:309-316. (Pubitemid 19035024)
-
(1989)
Cancer
, vol.63
, Issue.2
, pp. 309-316
-
-
Lee, T.-K.1
Horner, R.D.2
Silverman, J.F.3
Chen, Y.-H.4
Jenny, C.5
Scarantino, C.W.6
-
125
-
-
52649163840
-
Prognostic effect of epithe-lial and stromal lymphocyte infiltration in non-small cell lung cancer
-
Al-Shibli KI, Donnem T, Al-Saad S, et al. Prognostic effect of epithe-lial and stromal lymphocyte infiltration in non-small cell lung cancer. Clin Cancer Res 2008;14:5220-5227.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 5220-5227
-
-
Al-Shibli, K.I.1
Donnem, T.2
Al-Saad, S.3
-
126
-
-
0347506020
-
+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers
-
DOI 10.1111/j.1349-7006.2003.tb01392.x
-
Wakabayashi O, Yamazaki K, Oizumi S, et al. CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers. Cancer Sci 2003;94:1003-1009. (Pubitemid 37521216)
-
(2003)
Cancer Science
, vol.94
, Issue.11
, pp. 1003-1009
-
-
Wakabayashi, O.1
Yamazaki, K.2
Oizumi, S.3
Hommura, F.4
Kinoshita, I.5
Ogura, S.6
Dosaka-Akita, H.7
Nishimura, M.8
-
127
-
-
31444439350
-
+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma
-
DOI 10.1038/sj.bjc.6602934, PII 6602934
-
Hiraoka K, Miyamoto M, Cho Y, et al. Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma. Br J Cancer 2006;94:275-280. (Pubitemid 43151547)
-
(2006)
British Journal of Cancer
, vol.94
, Issue.2
, pp. 275-280
-
-
Hiraoka, K.1
Miyamoto, M.2
Cho, Y.3
Suzuoki, M.4
Oshikiri, T.5
Nakakubo, Y.6
Itoh, T.7
Ohbuchi, T.8
Kondo, S.9
Katoh, H.10
-
128
-
-
0034974069
-
Prognostic markers in resectable non-small cell lung cancer: A multivariate analysis
-
Pelletier MP, Edwardes MD, Michel RP, et al. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis. Can JSurg 2001;44:180-188. (Pubitemid 32538769)
-
(2001)
Canadian Journal of Surgery
, vol.44
, Issue.3
, pp. 180-188
-
-
Pelletier, M.P.1
Edwardes, M.D.D.B.2
Michel, R.P.3
Halwani, F.4
Morin, J.E.5
-
129
-
-
0036021723
-
Immunologic parameters as significant prognostic factors in lung cancer
-
DOI 10.1016/S0169-5002(02)00100-9, PII S0169500202001009
-
Nakamura H, Saji H, Ogata A, et al. Immunologic parameters as significant prognostic factors in lung cancer. Lung Cancer 2002;37: 161-169. (Pubitemid 34831808)
-
(2002)
Lung Cancer
, vol.37
, Issue.2
, pp. 161-169
-
-
Nakamura, H.1
Saji, H.2
Ogata, A.3
Hosaka, M.4
Hagiwara, M.5
Kawasaki, N.6
Konaka, C.7
Kato, H.8
-
130
-
-
63749090476
-
A central role for Foxp3 + regulatory T cells in K-Ras-driven lung tumorigenesis
-
Granville CA, Memmott RM, Balogh A, et al. A central role for Foxp3 + regulatory T cells in K-Ras-driven lung tumorigenesis. PLoS One 2009;4:e5061.
-
(2009)
PLoS One
, vol.4
-
-
Granville, C.A.1
Memmott, R.M.2
Balogh, A.3
-
131
-
-
77951877847
-
Tumor-infiltrating Foxp3 + regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer
-
Shimizu K, Nakata M, Hirami Y, et al. Tumor-infiltrating Foxp3 + regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer. J Thorac Oncol 2010;5:585-590.
-
(2010)
J Thorac Oncol
, vol.5
, pp. 585-590
-
-
Shimizu, K.1
Nakata, M.2
Hirami, Y.3
-
132
-
-
33845590308
-
+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients
-
DOI 10.1002/cncr.22282
-
Petersen RP, Campa MJ, Sperlazza J, et al. Tumor infiltrating Foxp3 + regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Cancer 2006;107:2866-2872. (Pubitemid 44937041)
-
(2006)
Cancer
, vol.107
, Issue.12
, pp. 2866-2872
-
-
Petersen, R.P.1
Campa, M.J.2
Sperlazza, J.3
Conlon, D.4
Joshi, M.-B.5
Harpole Jr., D.H.6
Patz Jr., E.F.7
-
133
-
-
20444464066
-
+ T regulatory cell activities in lung cancer
-
DOI 10.1158/0008-5472.CAN-05-0141
-
Sharma S, Yang SC, Zhu L, et al. Tumor cyclooxygenase-2/prosta-glandin E2-dependent promotion of FOXP3 expression and CD4+ CD25 + T regulatory cell activities in lung cancer. Cancer Res 2005; 65:5211-5220. (Pubitemid 40827331)
-
(2005)
Cancer Research
, vol.65
, Issue.12
, pp. 5211-5220
-
-
Sharma, S.1
Yang, S.-C.2
Zhu, L.3
Reckamp, K.4
Gardner, B.5
Baratelli, F.6
Huang, M.7
Batra, R.K.8
Dubinett, S.M.9
-
134
-
-
77957342046
-
Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancer
-
Donnem T, Al-Shibli K, Andersen S, et al. Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancer. Cancer 2010;116:4318-4325.
-
(2010)
Cancer
, vol.116
, pp. 4318-4325
-
-
Donnem, T.1
Al-Shibli, K.2
Andersen, S.3
-
135
-
-
0034858104
-
High number of tumour-infiltrating lymphocytes is associated with apoptosis in non-small cell lung carcinoma
-
Tormanen-Napankangas U, Soini Y, Paakko P. High number of tu-mour-infiltrating lymphocytes is associated with apoptosis in non-small cell lung carcinoma. APMIS 2001;109:525-532. (Pubitemid 32844260)
-
(2001)
APMIS
, vol.109
, Issue.7-8
, pp. 525-532
-
-
Tormanen-Napankangas, U.1
Soini, Y.2
Paakko, P.3
-
136
-
-
0033991155
-
Immune cell infiltrates and prognosis in primary carcinoma of the lung
-
Johnson SK, Kerr KM, Chapman AD, et al. Immune cell infiltrates and prognosis in primary carcinoma of the lung. Lung Cancer 2000;27:27-35.
-
(2000)
Lung Cancer
, vol.27
, pp. 27-35
-
-
Johnson, S.K.1
Kerr, K.M.2
Chapman, A.D.3
-
137
-
-
0024315246
-
The functional deficiency of B lymphocytes in patients with lung cancer is due to inadequate T-cell help and excessive suppression by T and non-T cells
-
Venkataraman M, Rao DS, Iyer BS, et al. The functional deficiency of B lymphocytes in patients with lung cancer is due to inadequate T-cell help and excessive suppression by T and non-T cells. Cancer Invest 1989;7:7-16. (Pubitemid 19192621)
-
(1989)
Cancer Investigation
, vol.7
, Issue.1
, pp. 7-16
-
-
Venkataraman, M.1
Rao, D.S.2
Iyer, B.S.3
Westerman, M.P.4
-
138
-
-
33845752914
-
P50 nuclear factor-κB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance
-
DOI 10.1158/0008-5472.CAN-06-1867
-
Saccani A, Schioppa T, Porta C, et al. p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 in-flammatory responses and antitumor resistance. Cancer Res 2006; 66:11432-11440. (Pubitemid 46009975)
-
(2006)
Cancer Research
, vol.66
, Issue.23
, pp. 11432-11440
-
-
Saccani, A.1
Schioppa, T.2
Porta, C.3
Biswas, S.K.4
Nebuloni, M.5
Vago, L.6
Bottazzi, B.7
Colombo, M.P.8
Mantovani, A.9
Sica, A.10
-
139
-
-
45149134605
-
'Re-educating' tumor-associated macrophages by targeting NF-κB
-
DOI 10.1084/jem.20080108
-
Hagemann T, Lawrence T, McNeish I, et al. "Re-educating" tumor-associated macrophages by targeting NF-kappaB. JExp Med 2008;205: 1261-1268. (Pubitemid 351831483)
-
(2008)
Journal of Experimental Medicine
, vol.205
, Issue.6
, pp. 1261-1268
-
-
Hagemann, T.1
Lawrence, T.2
McNeish, I.3
Charles, K.A.4
Kulbe, H.5
Thompson, R.G.6
Robinson, S.C.7
Balkwill, F.R.8
-
140
-
-
0015513014
-
Postoperative empy-ema improves survival in lung cancer. Documentation and analysis of a natural experiment
-
Ruckdeschel JC, Codish SD, Stranahan A, et al. Postoperative empy-ema improves survival in lung cancer. Documentation and analysis of a natural experiment. N Engl JMed 1972;287:1013-1017.
-
(1972)
N Engl JMed
, vol.287
, pp. 1013-1017
-
-
Ruckdeschel, J.C.1
Codish, S.D.2
Stranahan, A.3
-
141
-
-
0015549790
-
BCG immunotherapy of pulmonary growths from intravenously transferred rat tumour cells
-
Baldwin RW, Pimm MV BCG immunotherapy of pulmonary growths from intravenously transferred rat tumour cells. Br J Cancer 1973;27: 48-54.
-
(1973)
Br J Cancer
, vol.27
, pp. 48-54
-
-
Baldwin, R.W.1
Pimm, M.V.2
-
142
-
-
0017287037
-
Regional immunotherapy of lung cancer with intrapleural B.C.G
-
McKneally MF, Maver C, Kausel HW. Regional immunotherapy of lung cancer with intrapleural B.C.G. Lancet 1976;1:377-379.
-
(1976)
Lancet
, vol.1
, pp. 377-379
-
-
McKneally, M.F.1
Maver, C.2
Kausel, H.W.3
-
143
-
-
65349096128
-
Immunotherapy in non-small-cell lung carcinoma: From inflammation to vaccination
-
Van den Heuvel MM, Burgers SA, van ZN. Immunotherapy in non-small-cell lung carcinoma: from inflammation to vaccination. Clin Lung Cancer 2009;10:99-105.
-
(2009)
Clin Lung Cancer
, vol.10
, pp. 99-105
-
-
Van Den Heuvel, M.M.1
Burgers, S.A.2
Van Zn3
-
144
-
-
0031877341
-
Partial regression in primary carcinoma of the lung: Does it occur?
-
Kerr KM, Johnson SK, King G, et al. Partial regression in primary carcinoma of the lung: does it occur? Histopathology 1998;33:55-63. (Pubitemid 28352572)
-
(1998)
Histopathology
, vol.33
, Issue.1
, pp. 55-63
-
-
Kerr, K.M.1
Johnson, S.K.2
King, G.3
Kennedy, M.M.4
Weir, J.5
Jeffrey, R.6
-
145
-
-
40449089463
-
The future of cancer vaccines for non-small-cell lung cancer: Ongoing trials
-
DOI 10.3816/CLC.2008.s.006
-
ChoudhuryA, PalmaM, Mellstedt H. The future of cancervaccines for non-small-cell lung cancer: ongoing trials. Clin Lung Cancer 2008; 9(Suppl 1):S37-S44. (Pubitemid 351345726)
-
(2008)
Clinical Lung Cancer
, vol.9
, Issue.SUPPL. 1
-
-
Choudhury, A.1
Palma, M.2
Mellstedt, H.3
-
146
-
-
40449133556
-
Early clinical trial experience with vaccine therapies in non-small-cell lung cancer
-
DOI 10.3816/CLC.2008.s.004
-
Ho C, Ochsenbein AF, Gautschi O, et al. Early clinical trial experience with vaccine therapies in non-small-cell lung cancer. Clin Lung Cancer 2008;9(Suppl 1):S20-S27. (Pubitemid 351345724)
-
(2008)
Clinical Lung Cancer
, vol.9
, Issue.SUPPL. 1
-
-
Ho, C.1
Ochsenbein, A.F.2
Gautschi, O.3
Davies, A.M.4
-
147
-
-
42549106307
-
Final results of a multi-center, double-blind, randomized, placebo-controlled phase II study to assess the efficacy of MAGE-A3 immunotherapeutic adjuvant therapy in stage IB/II non-small cell lung cancer (NSCLC)
-
Vansteenkiste J, Zielinski M, Linder A, et al. Final results of a multi-center, double-blind, randomized, placebo-controlled phase II study to assess the efficacy of MAGE-A3 immunotherapeutic adjuvant therapy in stage IB/II non-small cell lung cancer (NSCLC). J Clin Oncol 2007;25(Suppl 18):398.
-
(2007)
J Clin Oncol
, vol.25
, Issue.SUPPL. 18
, pp. 398
-
-
Vansteenkiste, J.1
Zielinski, M.2
Linder, A.3
-
148
-
-
34547661985
-
Butts C L-BLP25: A peptide vaccine strategy in non small cell lung cancer
-
Sangha R, Butts C L-BLP25: a peptide vaccine strategy in non small cell lung cancer. Clin Cancer Res 2007;13:s4652-s4654.
-
(2007)
Clin Cancer Res
, vol.13
-
-
Sangha, R.1
-
149
-
-
27244449289
-
Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer
-
DOI 10.1200/JCO.2005.13.011
-
Butts C, Murray N, Maksymiuk A, et al. Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer. J Clin Oncol 2005;23:6674-6681. (Pubitemid 46190262)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.27
, pp. 6674-6681
-
-
Butts, C.1
Murray, N.2
Maksymiuk, A.3
Goss, G.4
Marshall, E.5
Soulieres, D.6
Cormier, Y.7
Ellis, P.8
Price, A.9
Sawhney, R.10
Davis, M.11
Mansi, J.12
Smith, C.13
Vergidis, D.14
Ellis, P.15
MacNeil, M.16
Palmer, M.17
|